Iran’s renewed currency slide and restrictions on maritime trade are intensifying pressure on a pharmaceutical system already struggling with rising prices, financing shortages and delayed insurance payments. As the dollar traded above 230,000 tomans on September 9, Iran’s Health Insurance Organization announced that it had incorporated the latest medicine price increases into its reimbursement systems.
Iran’s Drug Costs Rise as the Rial Falls and…
Iran’s renewed currency slide and restrictions on maritime trade are intensifying pressure on a pharmaceutical system already struggling with rising prices, financing shortages and delayed insurance payments. As the dollar traded above 230,000 tomans on September 9, Iran’s Health Insurance Organization announced that it had incorporated the latest medicine price increases into its reimbursement systems.